{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:25:03Z","timestamp":1648977903926},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T00:00:00Z","timestamp":1234828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10096-009-0711-y","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T14:00:58Z","timestamp":1234792858000},"page":"807-811","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis"],"prefix":"10.1007","volume":"28","author":[{"given":"E.","family":"Force","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Taberner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dom\u00e9nech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F.","family":"Viladrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,17]]},"reference":[{"key":"711_CR1","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","volume":"343","author":"CG Whitney","year":"2000","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A et al (2000) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343:1917\u20131924. doi: 10.1056\/NEJM200012283432603","journal-title":"N Engl J Med"},{"key":"711_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/13543784.13.4.393","volume":"13","author":"PH Cottagnoud","year":"2004","unstructured":"Cottagnoud PH, T\u00e4uber MG (2004) New therapies for pneumococcal meningitis. Expert Opin Investig Drugs 13:393\u2013401. doi: 10.1517\/13543784.13.4.393","journal-title":"Expert Opin Investig Drugs"},{"key":"711_CR3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM et al (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267\u20131284. doi: 10.1086\/425368","journal-title":"Clin Infect Dis"},{"key":"711_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/peds.99.2.289","volume":"99","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"1997","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases (1997) Therapy for children with invasive pneumococcal infections. Pediatrics 99:289\u2013299. doi: 10.1542\/peds.99.2.289","journal-title":"Pediatrics"},{"key":"711_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/34.1.175","volume":"34","author":"R Dagan","year":"1994","unstructured":"Dagan R, Velghe L, Rodda JL, Klugman KP (1994) Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother 34:175\u2013179. doi: 10.1093\/jac\/34.1.175","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"711_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/36.suppl_A.85","volume":"36","author":"E Schmutzhard","year":"1995","unstructured":"Schmutzhard E, Williams KJ, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A (1995) A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. J Antimicrob Chemother 36(Suppl A):85\u201397","journal-title":"J Antimicrob Chemother"},{"key":"711_CR7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.39.5.1140","volume":"39","author":"KP Klugman","year":"1995","unstructured":"Klugman KP, Dagan R; Meropenem Study Group (1995) Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 39:1140\u20131146","journal-title":"Antimicrob Agents Chemother"},{"key":"711_CR8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00006454-199907000-00004","volume":"18","author":"CM Odio","year":"1999","unstructured":"Odio CM, Puig JR, Feris JM, Khan WN, Rodriguez WJ, McCracken GH Jr et al (1999) Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J 18:581\u2013590. doi: 10.1097\/00006454-199907000-00004","journal-title":"Pediatr Infect Dis J"},{"key":"711_CR9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s100960050421","volume":"18","author":"CM Gerber","year":"1999","unstructured":"Gerber CM, Cottagnoud M, Neftel KA, T\u00e4uber MG, Cottagnoud P (1999) Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. Eur J Clin Microbiol Infect Dis 18:866\u2013870. doi: 10.1007\/s100960050421","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"711_CR10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.37.8.1630","volume":"37","author":"IR Friedland","year":"1993","unstructured":"Friedland IR, Paris M, Ehrett S, Hickey S, Olsen K, McCracken GH Jr (1993) Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 37:1630\u20131636","journal-title":"Antimicrob Agents Chemother"},{"key":"711_CR11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10096-008-0492-8","volume":"27","author":"E Force","year":"2008","unstructured":"Force E, Taberner F, Cabellos C, Ribes S, Dom\u00e9nech A, Tubau F et al (2008) Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis. Eur J Clin Microbiol Infect Dis 27:685\u2013690","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"711_CR12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/AAC.36.7.1577","volume":"36","author":"M Fukasawa","year":"1992","unstructured":"Fukasawa M, Sumita Y, Harabe ET, Tanio T, Nouda H, Kohzuki T et al (1992) Stability of meropenem and effect of 1\u03b2-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrob Agents Chemother 36:1577\u20131579","journal-title":"Antimicrob Agents Chemother"},{"key":"711_CR13","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A5","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2000","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS) (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A5, 5th edn. NCCLS, Wayne, PA, USA","edition":"5"},{"key":"711_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.micinf.2006.12.013","volume":"9","author":"JM Maiques","year":"2007","unstructured":"Maiques JM, Dom\u00e9nech A, Cabellos C, Fern\u00e1ndez A, Ribes S, Tubau F et al (2007) Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa. Microbes Infect 9:435\u2013441. doi: 10.1016\/j.micinf.2006.12.013","journal-title":"Microbes Infect"},{"key":"711_CR15","first-page":"295","volume-title":"Antibiotics in laboratory medicine","author":"K Chapin-Robertson","year":"1991","unstructured":"Chapin-Robertson K, Edberg SC (1991) Measurement of antibiotics in human body fluids: techniques and significance. In: Lorian V (ed) Antibiotics in laboratory medicine. Williams and Wilkins, New York, pp 295\u2013366"},{"issue":"Suppl A","key":"711_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/36.suppl_A.73","volume":"36","author":"K Nairn","year":"1995","unstructured":"Nairn K, Shepherd GL, Edwards JR (1995) Efficacy of meropenem in experimental meningitis. J Antimicrob Chemother 36(Suppl A):73\u201384","journal-title":"J Antimicrob Chemother"},{"key":"711_CR17","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1086\/323021","volume":"33","author":"PM Tilburg van","year":"2001","unstructured":"van Tilburg PM, Bogaert D, Sluijter M, Jansz AR, de Groot R, Hermans PW (2001) Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains. Clin Infect Dis 33:e93\u2013e96. doi: 10.1086\/323021","journal-title":"Clin Infect Dis"},{"key":"711_CR18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/49.3.507","volume":"49","author":"J Mart\u00ednez-Lacasa","year":"2002","unstructured":"Mart\u00ednez-Lacasa J, Cabellos C, Martos A, Fern\u00e1ndez A, Tubau F, Viladrich PF et al (2002) Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother 49:507\u2013513. doi: 10.1093\/jac\/49.3.507","journal-title":"J Antimicrob Chemother"},{"key":"711_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006454-200206000-00034","volume":"21","author":"SL Kaplan","year":"2002","unstructured":"Kaplan SL (2002) Management of pneumococcal meningitis. Pediatr Infect Dis J 21:589\u2013591. doi: 10.1097\/00006454-200206000-00034","journal-title":"Pediatr Infect Dis J"},{"key":"711_CR20","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/AAC.39.12.2798","volume":"39","author":"KP Giron","year":"1995","unstructured":"Giron KP, Gross ME, Musher DM, Williams TW Jr, Tharappel RA (1995) In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother 39:2798\u20132800","journal-title":"Antimicrob Agents Chemother"},{"key":"711_CR21","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.40.6.1573","volume":"40","author":"F Tubau","year":"1996","unstructured":"Tubau F, Cabellos C, Li\u00f1ares J (1996) Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or \u03b2-lactam antibiotics against Streptococcus pneumoniae. Antimicrob Agents Chemother 40:1573\u20131574","journal-title":"Antimicrob Agents Chemother"},{"key":"711_CR22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jac\/dki323","volume":"56","author":"S Ribes","year":"2005","unstructured":"Ribes S, Taberner F, Dom\u00e9nech A, Cabellos C, Tubau F, Li\u00f1ares J et al (2005) Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. J Antimicrob Chemother 56:979\u2013982. doi: 10.1093\/jac\/dki323","journal-title":"J Antimicrob Chemother"},{"key":"711_CR23","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.38.11.2655","volume":"38","author":"CP Doit","year":"1994","unstructured":"Doit CP, Bonacorsi SP, Fremaux AJ, Sissia G, Cohen R, Geslin PL et al (1994) In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob Agents Chemother 38:2655\u20132659","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0711-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-009-0711-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0711-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:13Z","timestamp":1559122453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-009-0711-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,17]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s10096-009-0711-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,17]]}}}